Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Ranbaxy Laboratories has settled all matters relating to possible patent litigation with GlaxoSmithKline relating to sumatriptan succinate tablets, the generic version of GlaxoSmithKline's Imitrex tablets.
Subscribe to our email newsletter
The terms of the settlement provide that Ranbaxy may distribute a generic version of sumatriptan succinate tablets (in the 25mg, 50mg and 100mg strengths) in the US with an expected launch date in December, 2008.